Study of airway sensitivity in primary ciliary dyskinesia
Part of Ear, nose & throat, Genetic & congenital, Lungs & breathing clinical trials.
This study looks at how the airways in people with primary ciliary dyskinesia (PCD) react to certain triggers. It aims to understand if these airways are more sensitive, which could help improve treatment for breathing problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of primary ciliary dyskinesia (PCD) through standard tests and genetic testing.
- You need to be at least 6 years old (there is no upper age limit).
- You must be able to perform lung function tests (like blowing into a tube). It's okay if past tests showed your airways can open up with medicine.
- You cannot have a current collapsed lung (pneumothorax) or a history of one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a breathing test called nasal nitric oxide can help improve care for people with primary ciliary dyskinesia (PCD) or related lung/sinus problems. The goal is to see if the test can better guide diagnosis and treatment planning.
This study invites people who have been told they may have, or who have confirmed, primary ciliary dyskinesia. It aims to better understand living with PCD and what helps people day to day.
This study tracks the health of children with primary ciliary dyskinesia (a rare condition affecting how tiny hairs in the lungs and sinuses move). By collecting information and samples, researchers hope to learn more about this disease in Chinese children.
This trial tests whether a stay at a thermal spa can improve symptoms of Primary Ciliary Dyskinesia (PCD), a genetic lung condition. It's for adults with stable PCD who haven't had a recent infection or spa treatment.
This study checks whether using “PCD diagnostics” helps clinicians make better care decisions for people being evaluated for PCD. You might be able to join if you’re referred for PCD diagnosis and can complete the study steps.
This study (RaDiCo-DCP) follows people who have a confirmed diagnosis of primary ciliary dyskinesia, a condition that can affect how your lungs clear mucus. The trial looks at long-term symptoms over time, which may help improve care planning and understanding of the condition.
Hear when a new Primary Ciliary Dyskinesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.